Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NDUFS1 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | NFS1 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | GPATCH4 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | DYM | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
mRNA | SCYL3 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
mRNA | NHLRC4 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
mRNA | KIAA1586 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
mRNA | SCNM1 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | TOP1MT | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
mRNA | CBWD7 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |